SUMMARY This study has identified IgG and IgM anticoagulant antibodies in the synovial membranes of patients suffering from haemophilia and rheumatoid arthritis (RA) but not in synovial tissues from normal subjects or in patients with other arthritides. In the majority of cases the antibody appeared to have the specificity of the lupus-like anticoagulant (LLA) seen in patients with systemic lupus erythematosus (SLE). The importance of these findings with regard to the treatment of certain cases of haemophilia and RA and the possible relation between the presence of these antibodies and viral infections is discussed.
Approximately 6% of patients suffering from haemophilia develop a systemic antibody for factor VIII C' which seriously complicates the treatment of this disorder and patients with rheumatoid arthritis (RA) have been reported to have developed acquired haemophilia for the same reason. 23 The cause of this complication is at present unknown. However, the histopathology of the synovial membrane in some RA cases closely resembled that of advanced haemophilic arthropathy, namely hyperplasia, round cell infiltration but more especially the presence of plasma cells together with deposits of haemosiderin. 4 Those observations suggested the possibility that an anticoagulant antibody can arise in the joint perhaps becoming systemic in some patients.
However, although our preliminary investigations4 demonstrated anticoagulant activity in synovial extracts from RA and haemophiliac patients, the specificity of these anticoagulants did not appear to be active against factor VIII C.
We report here a more comprehensive investigation of this phenomenon and the results of our attempts to characterise (a) the antibody class(es) and (b) the coagulation reactions involved. Material and methods One hundred and six specimens of synovial membrane from patients suffering from haemophilia, Accepted for publication 28 September 1981 Christmas disease, rheumatoid arthritis (RA), osteoarthrosis (OA) and other rheumatic disorders have been examined. Six specimens of normal synovial membrane were also examined.
SYNOVIAL MEMBRANE EXTRACTS
The method of extraction has been described previously. 4 In brief the synovial membranes were homogenised and extracted in physiological saline. All extracts were then heated at 56°C and absorbed with aluminium hydroxide. Each extract was concentrated fivefold then assayed for total protein.
AGAROSE GEL DIFFUSION TEST (AGDT)
The AGDT was employed as a preliminary test for the detection and measurement of coagulation inhibitors in these extracts. The methodology for this test is fully described elsewhere.5 6 An antibody reference standard plasma containing 50 New Oxford Units (NOU)/ml of antifactor VMI C was employed to compare results.7 Before use the plasma was heated at 56°C for 30 min and absorbed with Al (OH)3 to remove all clotting factors. Results were expressed as equivalents of factor VIII C antibody units (AGDT units of inhibitor).
An example of titration of inhibitors by this method is given in Fig. 1 tion and the remaining four contained less than 4 inhibitor units/ml. With the technique employed it was found that clotting tests with specimens containing less than 4 inhibitor units/ml were inconclusive. However, Fig. 4a shows a repeat of the KCCT and PT on extract H14 (shown in Fig. 2 ) which contained only 4 inhibitor units/ml and the similarity of the clotting reactions in the two separate tests is remarkable.
RHEUMATOID FACTOR TESTS Table 3 shows the rheumatoid factor (RF) status of all "inhibitor-positive" patients and it will be seen that there was no correlation between the presence of RF in the blood and inhibitors in the synovial tissues. The results of three tests are shown in and 6b. It will be seen that anti-IgG pi reduction in the KCCT with all the extri and with the antifactor VIII C standard. I of extract HI 18 (Fig. 6b) Although the LLA is probably the most prevalent of all systemic inhibitors2 9 the identification of this antibody in the majority of synovial extracts from patients with haemophilia and RA was quite unexpected and raises the possibility that there is some common factor operating in these two diseases. Clinically, the presence of LLA in the blood seldom gives rise to spontaneous bleeding. It 
